Cargando…

Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn’s Disease: The Patient Perspective

Crohn’s disease (CD) is a chronic, incurable and relapsing disease involving any part of the gastrointestinal tract and exclusive enteral nutrition (EEN) is first-line therapy. Few studies have examined the patient experience of EEN. The aim of this study was to assess the child’ s experiences of EE...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Stephanie Christine, Wall, Catherine L, Gearry, Richard B, Day, Andrew S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192588/
https://www.ncbi.nlm.nih.gov/pubmed/37214167
http://dx.doi.org/10.5223/pghn.2023.26.3.165
_version_ 1785043655142146048
author Brown, Stephanie Christine
Wall, Catherine L
Gearry, Richard B
Day, Andrew S
author_facet Brown, Stephanie Christine
Wall, Catherine L
Gearry, Richard B
Day, Andrew S
author_sort Brown, Stephanie Christine
collection PubMed
description Crohn’s disease (CD) is a chronic, incurable and relapsing disease involving any part of the gastrointestinal tract and exclusive enteral nutrition (EEN) is first-line therapy. Few studies have examined the patient experience of EEN. The aim of this study was to assess the child’ s experiences of EEN, to identify problematic themes and understand the child’s mindset. Children with CD who previously completed EEN were recruited to complete a survey. All data were analyzed using Microsoft Excel and reported as N (%). Forty-four children (mean age 11.3 years) consented to participate. Sixty-eight percent of children reported limited formula flavors as the most challenging aspect and 68% of children identified ‘support’ to be important. This study highlights the psychological impact of chronic disease and its therapies on children. Providing adequate support is essential to insure EEN is successful. Further studies are required to determine psychological support strategies for children taking EEN.
format Online
Article
Text
id pubmed-10192588
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
record_format MEDLINE/PubMed
spelling pubmed-101925882023-05-19 Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn’s Disease: The Patient Perspective Brown, Stephanie Christine Wall, Catherine L Gearry, Richard B Day, Andrew S Pediatr Gastroenterol Hepatol Nutr Short Communication Crohn’s disease (CD) is a chronic, incurable and relapsing disease involving any part of the gastrointestinal tract and exclusive enteral nutrition (EEN) is first-line therapy. Few studies have examined the patient experience of EEN. The aim of this study was to assess the child’ s experiences of EEN, to identify problematic themes and understand the child’s mindset. Children with CD who previously completed EEN were recruited to complete a survey. All data were analyzed using Microsoft Excel and reported as N (%). Forty-four children (mean age 11.3 years) consented to participate. Sixty-eight percent of children reported limited formula flavors as the most challenging aspect and 68% of children identified ‘support’ to be important. This study highlights the psychological impact of chronic disease and its therapies on children. Providing adequate support is essential to insure EEN is successful. Further studies are required to determine psychological support strategies for children taking EEN. The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2023-05 2023-05-11 /pmc/articles/PMC10192588/ /pubmed/37214167 http://dx.doi.org/10.5223/pghn.2023.26.3.165 Text en Copyright © 2023 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Brown, Stephanie Christine
Wall, Catherine L
Gearry, Richard B
Day, Andrew S
Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn’s Disease: The Patient Perspective
title Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn’s Disease: The Patient Perspective
title_full Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn’s Disease: The Patient Perspective
title_fullStr Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn’s Disease: The Patient Perspective
title_full_unstemmed Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn’s Disease: The Patient Perspective
title_short Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn’s Disease: The Patient Perspective
title_sort exclusive enteral nutrition for the treatment of pediatric crohn’s disease: the patient perspective
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192588/
https://www.ncbi.nlm.nih.gov/pubmed/37214167
http://dx.doi.org/10.5223/pghn.2023.26.3.165
work_keys_str_mv AT brownstephaniechristine exclusiveenteralnutritionforthetreatmentofpediatriccrohnsdiseasethepatientperspective
AT wallcatherinel exclusiveenteralnutritionforthetreatmentofpediatriccrohnsdiseasethepatientperspective
AT gearryrichardb exclusiveenteralnutritionforthetreatmentofpediatriccrohnsdiseasethepatientperspective
AT dayandrews exclusiveenteralnutritionforthetreatmentofpediatriccrohnsdiseasethepatientperspective